Risk Management
3
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Prism
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
Assessment of a Multifaceted Risk Management Program in French Multiprofessional Offices in Primary Care
Validation Study of ClassIntra®
Multiple Algorithms System Of All Scores in Embolism (MOSE)
Research Network
Common Treatments
- Prism1
- Observational Study1
Active Sponsors
- University Magna Graecia1
- Hospices Civils de Lyon1
- University Hospital, Basel, Switzerland1
Top Investigators
University Hospital, Basel, Switzerland
Hospices Civils de Lyon, Pôle Information Médicale Evaluation Recherche
Federico II University
University Magna Graecia of Catanzaro
University Magna Graecia of Catanzaro
Related Conditions
- Patient Safety2
- Primary Health Care1
- Postoperative Complications1
- Risk Assessment1
- Intraoperative Complications1